Cours RegeneRx Biopharmaceuticals Inc OTC Bulletin Board
Actions
Produits pharmaceutiques
CA 2021 | 76,76 k 69,49 k | CA 2022 | 76,76 k 69,49 k | Capitalisation | 19,94 M 18,05 M |
---|---|---|---|---|---|
Résultat net 2021 | -1 M -905 k | Résultat net 2022 | -1 M -905 k | VE / CA 2021 | 298 x |
Trésorerie nette 2021 | 66,69 k 60,38 k | Dette nette 2022 | 1,16 M 1,05 M | VE / CA 2022 | 275 x |
PER 2021 |
-13,9
x | PER 2022 |
-11,5
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 55,86% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 86 | 13/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Founder | 86 | 13/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01/01/02 |
Varia. 1 janv. | Capi. | |
---|---|---|
-3,89% | 88,14 Md | |
+1,45% | 40,51 Md | |
-15,16% | 31,67 Md | |
+51,27% | 24,62 Md | |
-14,27% | 15,65 Md | |
-14,38% | 12,07 Md | |
-7,87% | 11,97 Md | |
-42,56% | 11,61 Md | |
+5,92% | 8,81 Md |